Skip to main content

Antibiotic Resistance Implications for Global Health and Novel Intervention Strategies: Workshop Summary (2010) / Chapter Skim
Currently Skimming:

Appendix B: Agenda
Pages 420-423

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 420...
... Hughes, M.D., Vice-Chair, Forum on Microbial Threats 9:15–10:00: Keynote Remarks: The Effects of Antibiotic and Pesticide Resistance on Public Health David Pimentel, Ph.D. Cornell University 10:00–10:30: Discussion 10:30–10:45: Break Session I Where Does Resistance Come From?
Read the entire page →
From page 421...
... McMaster University 2:00–2:30: Antibiotic-Induced Resistance Flow Patrice Courvalin, M.D. Institut Pasteur 2:30–3:00: The Contribution of Antimicrobial Use in Food Animal Production to the Emergence of Antimicrobial Resistance in Human Pathogens Jørgen Schlundt, Ph.D., D.V.M.
Read the entire page →
From page 422...
... University of California, Los Angeles 5:15–5:45: Hospital and Societal Costs of AMR Infections Robert Weinstein, M.D. John Stroger Hospital of Cook County 5:45–6:15: Questions and Discussion DAy 2: APRIL 7, 2010 Paths Forward: Novel Therapeutic Approaches, Mitigation, Intervention 8:15–8:30: Continental Breakfast 8:30–8:45: Summary of Day 1 and Preview of Day 2: David Relman, M.D.
Read the entire page →
From page 423...
... 1:15–2:15: Prudent Use, Stewardship, Market Incentives, and Global Engagement Stuart Levy, M.D., Tufts University and the Alliance for Prudent Use of Antibiotics Shelley Hearne, Ph.D., The Pew Charitable Trusts Jeffrey Levi, Ph.D., Trust for America's Health 2:15–4:30: Open Discussion with Panelists, Forum Members, and Audience Julian Davies, Ph.D., University of British Columbia Gerard Wright, Ph.D., McMaster University Jørgen Schlundt, Ph.D., D.V.M., World Health Organization Brad Spellberg, M.D., University of California, Los Angeles Ed Cox, M.D., M.P.H., Food and Drug Administration/Center for Drug Evaluation and Research 4:30–5:00: James Hughes, M.D., and David Relman, M.D., Wrap-Up and Adjournment 5:00: Meeting Adjourns
Read the entire page →

Key Terms

  • british columbia
  • drug discovery
  • novel approaches
  • james hughes
  • gerard wright

  • mcmaster university
  • antibiotic resistance
  • brad spellberg
  • session iii
  • migration health

  • radical mechanisms
  • frederick sparling
  • stokes cleveland
  • management issues
  • louis stokes

  • novel therapeutic
  • charitable trusts
  • pew charitable
  • european centre
  • global engagement

  • david heymann
  • david relman
  • therapeutic approaches
  • shelley hearne
  • health consultants

  • john stroger
  • mechanisms leading
  • antimicrobial resistance
  • iii novel
  • cook county


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.